AI Bias Analysis
4 models · Takes ~15 seconds
Novo Nordisk on Wednesday narrowly improved its financial guidance for a year where it still sees profit and sales falling after the fastest take-up in weight-loss drug history for its Wegovy pill.
Source
MarketWatch
Opens original article in a new tab
African ports are struggling to capitalize on a surge in shipping traffic as the Middle East conflict disrupts other key global trade routes. Bloomberg's Chief Africa Correspondent Jennifer Zabasajja explains on Horizons Middle East & Africa. (Source: Bloomberg)
This earnings season has delivered plenty of good news for the artificial intelligence trade, but instead of bidding up Nvidia Corp. shares, investors have been dumping them.
It’s not just inflation concerns that have been pushing U.K. yields to multi-decade highs
Novo Nordisk raised its outlook for 2026 after a strong performance from its newly launched Wegovy pill.
